Femasys Inc (FEMY): Cash & Equivalents

Annual figures by period end, from SEC filings.

$9.27M
As of 2025-12-31
$1.44M
As of 2026-06-30
-10.6%
3-year compound annual growth
+22.8%
5-year compound annual growth
$24.78M2020-12-31: $3.32M2021-12-31: $24.78M2022-12-31: $12.96M2023-12-31: $21.72M2024-12-31: $3.45M2025-12-31: $9.27M$9.27M
2020-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$9.27M+168.5%2026-03-31, Balance as of period end
2024-12-31$3.45M-84.1%2026-03-31, Balance as of period end
2023-12-31$21.72M+67.5%2025-03-27, Balance as of period end
2022-12-31$12.96M-47.7%2024-03-28, Balance as of period end
2021-12-31$24.78M+646.0%2023-07-24, Balance as of period end
2020-12-31$3.32Mn/a2022-03-24, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Femasys Inc (FEMY)2025-12-31$9.27M+168.5%
QHSLab, Inc. (USAQ)2025-12-31$636.2K+304.8%
Vycor Medical Inc (VYCO)2025-12-31$87.0K-17.7%
OSR Health, Inc. (OSRH)2025-12-31$1.70M+397.8%
EBR Systems, Inc. (NONE.)2025-12-31$5.79M-16.2%
Nuo Therapeutics, Inc. (AURX)2025-12-31$548.9K+93.5%
IceCure Medical Ltd. (ICCM)2025-12-31$8.90M+17.6%
Tenon Medical, Inc. (TNON)2025-12-31$3.76M-42.5%
Intelligent Bio Solutions Inc. (INBS)2026-06-30$3.99M+291.4%

Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗